Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19

Introduction: During the COVID-19 pandemic, widespread introduction of SARS-CoV-2 antibody testing was introduced without a full understanding of the assays performance or the antibody kinetics following infection with SARS-CoV-2. Methods: We performed an evaluation of 2 anti-SARS-CoV-2 antibody ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrington, David, Azim, Tahira, Rosmarin, Caryn, Cutino-Moguel, Teresa, Hopkins, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178064/
https://www.ncbi.nlm.nih.gov/pubmed/34224944
http://dx.doi.org/10.1016/j.diagmicrobio.2021.115449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178064/
https://www.ncbi.nlm.nih.gov/pubmed/34224944
http://dx.doi.org/10.1016/j.diagmicrobio.2021.115449

Ejemplares similares